Gene Symbol,Name,Entrez GeneId,Genome Location,Tier,Chr Band,Mutation Types,Synonyms
ABI1,abl-interactor 1,10006,10:26748570-26860863,1,10p11.2,T,"10006,ABI1,ENSG00000136754,Q8IZP0,SSH3BP1"
ABL1,v-abl Abelson murine leukemia viral oncogene homolog 1,25,9:130835447-130885683,1,9q34.1,"T, Mis","25,ABL,ABL1,ENSG00000097007,P00519"
ABL2,"c-abl oncogene 2, non-receptor tyrosine kinase",27,1:179107718-179143044,1,1q24-q25,T,"27,ABL2,ABLL,ENSG00000143322,P42684"
ACKR3,atypical chemokine receptor 3,57007,2:236580466-236581554,1,2q37.3,T,"A8K6J4,ACKR3,CMKOR1,CXCR7,ENSG00000144476,P25106,Q53RV4,Q8NE10,Q92938,Q92986"
ACSL3,acyl-CoA synthetase long-chain family member 3,2181,2:222908773-222941654,1,2q36,T,"2181,ACSL3,ENSG00000123983,FACL3,O95573"
ACVR1,"activin A receptor, type I",90,2:157737531-157799493,1,2q23-q24,Mis,"90,ACVR1,ACVRLK2,ENSG00000115170,Q04771"
ACVR2A,activin A receptor type 2A,92,2:147845153-147927274,1,2q22.3-q23.1,"Mis, N, F","92,ACVR2,ACVR2A,ENSG00000121989,P27037"
AFF1,"AF4/FMR2 family, member 1",4299,4:87007409-87135702,1,4q21,T,"4299,AFF1,ENSG00000172493,MLLT2,P51825,PBM1"
AFF3,"AF4/FMR2 family, member 3",3899,2:99551474-100104454,1,2q11.2-q12,T,"3899,AFF3,ENSG00000144218,LAF4,P51826"
AFF4,"AF4/FMR2 family, member 4",27125,5:132881059-132937189,1,5q31,T,"27125,AFF4,ENSG00000072364,Q9UHB7"
AKT1,v-akt murine thymoma viral oncogene homolog 1,207,14:104770341-104792643,1,14q32.32,Mis,"207,AKT1,ENSG00000142208,P31749"
AKT2,v-akt murine thymoma viral oncogene homolog 2,208,19:40233872-40265267,1,19q13.1-q13.2,A,"208,AKT2,ENSG00000105221,P31751"
ALK,anaplastic lymphoma kinase (Ki-1),238,2:29193224-29920659,1,2p23,"T, Mis, A","238,ALK,ENSG00000171094,Q9UM73"
AMER1,APC membrane recruitment protein 1,139285,X:64186117-64193286,1,Xq11.2,"F, D, N, Mis","139285,AMER1,ENSG00000184675,FAM123B,Q5JTC6"
APC,adenomatous polyposis of the colon gene,324,5:112754891-112844126,1,5q21,"D, Mis, N, F, S","324,APC,ENSG00000134982,P25054"
APOBEC3B,apolipoprotein B mRNA editing enzyme catalytic subunit 3B,9582,22:38982454-38992445,1,22q13.1,D,"9582,APOBEC3B,ENSG00000179750,Q9UH17"
AR,Androgen Receptor,367,X:67545147-67723841,1,Xq12,Mis,"367,AR,DHTR,ENSG00000169083,SBMA"
ARHGAP26,Rho GTPase activating protein 26,23092,5:142770762-143222446,1,5q31,"T, F, S","23092,ARHGAP26,ENSG00000145819,Q9UNA1"
ARHGEF12,RHO guanine nucleotide exchange factor (GEF) 12 (LARG),23365,11:120337244-120485077,1,11q23.3,T,"23365,ARHGEF12,ENSG00000196914,Q9NZN5"
ARID1A,AT rich interactive domain 1A (SWI-like),8289,1:26696404-26780756,1,1p35.3,"Mis, N, F, S, D, T","8289,ARID1A,C1orf4,ENSG00000117713,O14497,SMARCF1"
ARID1B,AT rich interactive domain 1B,57492,6:156778104-157207891,1,6q25.1,"Mis, F, N, O","57492,ARID1B,ENSG00000049618"
ARID2,AT rich interactive domain 2,196528,12:45729837-45905078,1,12q12,"N, S, F","196528,ARID2,ENSG00000189079,Q68CP9"
ARNT,aryl hydrocarbon receptor nuclear translocator,405,1:150812021-150876567,1,1q21,T,"405,ARNT,ENSG00000143437,P27540"
ASPSCR1,"alveolar soft part sarcoma chromosome region, candidate 1",79058,17:81977648-82017323,1,17q25,T,"79058,ASPSCR1,ENSG00000169696,Q9BZE9"
ASXL1,additional sex combs like 1,171023,20:32358776-32437338,1,20q11.1,"F, N, Mis","171023,ASXL1,ENSG00000171456,Q8IXJ9"
ATF1,activating transcription factor 1,466,12:50780147-50819780,1,12q13,T,"466,ATF1,ENSG00000123268,P18846"
ATIC,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,471,2:215312144-215349656,1,2q35,T,"471,ATIC,ENSG00000138363,P31939"
ATM,ataxia telangiectasia mutated,472,11:108227625-108365508,1,11q22.3,"D, Mis, N, F, S","472,ATA,ATC,ATD,ATDC,ATM,ENSG00000149311,Q13315"
ATP1A1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",476,1:116373512-116404444,1,1p21,"Mis, O","476,ATP1A1,ENSG00000163399,P05023"
ATP2B3,"ATPase, Ca++ transporting, plasma membrane 3",492,X:153536248-153580003,1,Xq28,O,"492,ATP2B3,CLA2,ENSG00000067842,Q16720,SCAX1"
ATR,ATR serine/threonine kinase,545,3:142449429-142578704,1,3q23,"F; Mis","545,ATR,ENSG00000175054,Q13535"
ATRX,alpha thalassemia/mental retardation syndrome X-linked,546,X:77508351-77786001,1,Xq21.1,"Mis, F, N","546,ATRX,ENSG00000085224,JMS,MRX52,P46100,RAD54"
AXIN1,axin 1,8312,16:288122-347025,1,16p13.3,"D, Mis, N, F, S","8312,AXIN1,ENSG00000103126,O15169"
AXIN2,axin 2,8313,17:65529976-65558620,1,17q24.1,"Mis, F, N","8313,AXIN2,ENSG00000168646,Q9Y2T1"
B2M,beta-2-microglobulin,567,15:44711547-44716342,1,15q21.1,"Mis, N, F","567,B2M,ENSG00000166710,P61769"
BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),8314,3:52402288-52409878,1,3p21.31-p21.2,"N, Mis, F, S, O","8314,BAP1,ENSG00000163930,Q92560"
BARD1,BRCA1 associated RING domain 1,580,2:214728676-214809569,1,2q35,Mis,"580,BARD1,ENSG00000138376,Q99728"
BAX,"BCL2 associated X, apoptosis regulator",581,19:48954929-48961097,1,19q13.33,"F, Mis","581,BAX,ENSG00000087088,Q07812"
BCL10,B-cell CLL/lymphoma 10,8915,1:85267627-85276352,1,1p22,T,"8915,BCL10,ENSG00000142867,O95999"
BCL11A,B-cell CLL/lymphoma 11A,53335,2:60460404-60553270,1,2p13,T,"53335,BCL11A,ENSG00000119866,EVI9,Q9H165"
BCL11B,B-cell CLL/lymphoma 11B  (CTIP2),64919,14:99174151-99271218,1,14q32.1,T,"64919,BCL11B,ENSG00000127152,Q9C0K0,ZNF856B"
BCL2,B-cell CLL/lymphoma 2,596,18:63128625-63318666,1,18q21.3,T,"596,BCL2,ENSG00000171791,P10415"
BCL3,B-cell CLL/lymphoma 3,602,19:44748791-44759615,1,19q13,T,"602,BCL3,BCL4,D19S37,ENSG00000069399,P20749"
BCL6,B-cell CLL/lymphoma 6,604,3:187722458-187733693,1,3q27,"T, Mis","604,BCL6,ENSG00000113916,P41182,ZNF51"
BCL7A,B-cell CLL/lymphoma 7A,605,12:122022092-122059163,1,12q24.1,T,"605,BCL7,BCL7A,ENSG00000110987,Q4VC05"
BCL9,B-cell CLL/lymphoma 9,607,1:147611837-147624864,1,1q21,T,"607,BCL9,ENSG00000116128,O00512"
BCL9L,B-cell CLL/lymphoma 9-like,283149,11:118898415-118909939,1,11q23.3,"Mis, F","283149,BCL9L,ENSG00000186174,Q86UU0"
BCOR,BCL6 corepressor,54880,X:40052109-40077929,1,Xp11.4,"F, N, S, T","54880,BCOR,ENSG00000183337,Q6W2J9"
BCORL1,BCL6 corepressor-like 1,63035,X:130005232-130056136,1,Xq25-q26.1,"Mis, N, F","63035,BCORL1,CXorf10,ENSG00000085185,Q5H9F3"
BCR,breakpoint cluster region,613,22:23180961-23315522,1,22q11.21,T,"613,BCR,BCR1,D22S11,ENSG00000186716,P11274"
BIRC3,baculoviral IAP repeat-containing 3,330,11:102324510-102337102,1,11q22,"D, F, N, T, Mis","330,API2,BIRC3,ENSG00000023445,Q13489"
BLM,Bloom Syndrome,641,15:90747393-90815279,1,15q26.1,"Mis, N, F","641,BLM,ENSG00000197299,P54132"
BMPR1A,"bone morphogenetic protein receptor, type IA",657,10:86876019-86923719,1,10q22.3,"Mis, N, F","657,ACVRLK3,ALK3,BMPR1A,CD292,ENSG00000107779,P36894"
BRAF,v-raf murine sarcoma viral oncogene homolog B1,673,7:140734597-140924703,1,7q34,"Mis, T, O","673,BRAF,ENSG00000157764,P15056"
BRCA1,familial breast/ovarian cancer gene 1,672,17:43045678-43124096,1,17q21,"D, Mis, N, F, S","672,BRCA1,ENSG00000012048,P38398"
BRCA2,familial breast/ovarian cancer gene 2,675,13:32316461-32398770,1,13q12,"D, Mis, N, F, S","675,BRCA2,ENSG00000139618,FACD,FANCD,FANCD1,P51587"
BRD3,bromodomain containing 3,8019,9:134033590-134053477,1,9q34,T,"8019,BRD3,ENSG00000169925,Q15059"
BRD4,bromodomain containing 4,23476,19:15249280-15273099,1,19p13.1,T,"23476,BRD4,ENSG00000141867,O60885"
BRIP1,BRCA1 interacting protein C-terminal helicase 1,83990,17:61683296-61861539,1,17q22,"F, N, Mis","83990,BRIP1,ENSG00000136492,Q9BX63"
BTG1,"B-cell translocation gene 1, anti-proliferative",694,12:92144080-92145535,1,12q22,T,"694,BTG1,ENSG00000133639,P62324"
BTK,Bruton agammaglobulinemia tyrosine kinase,695,X:101349885-101375284,1,Xq21.33-q22,Mis,"695,AGMX1,BTK,ENSG00000010671,IMD1,Q06187"
BUB1B,BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast),701,15:40161221-40220759,1,15q15,"Mis, N, F, S","701,BUB1B,ENSG00000156970,O60566"
C2orf44,chromosome 2 open reading frame 44,80304,2:24030933-24039494,1,2p23.3,T,"80304,C2orf44,ENSG00000163026,Q9H6R7"
CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",776,3:53495167-53811406,1,3p14.3,Mis,"776,CACNA1D,CACNL1A2,CCHL1A2,ENSG00000157388,Q01668"
CALR,calreticulin,811,19:12938680-12943913,1,19p13.3-p13.2,"F, Mis","811,CALR,ENSG00000179218,P27797"
CAMTA1,calmodulin binding transcription activator 1,23261,1:6785531-7766491,1,1p36.31-p36.23,T,"23261,CAMTA1,ENSG00000171735,Q9Y6Y1"
CANT1,calcium activated nucleotidase 1,124583,17:78993550-78997622,1,17q25,T,"124583,CANT1,ENSG00000171302,Q8WVQ1"
CARD11,"caspase recruitment domain family, member 11",84433,7:2906638-2958506,1,7p22,Mis,"84433,CARD11,ENSG00000198286,Q9BXL7"
CARS,cysteinyl-tRNA synthetase,833,11:3001114-3057367,1,11p15.5,T,"833,CARS,ENSG00000110619,P49589"
CASC5,cancer susceptibility candidate 5,57082,15:40602933-40654977,1,15q14,T,"57082,CASC5,ENSG00000137812,MCPH4,Q8NG31"
CASP8,"caspase 8, apoptosis-related cysteine peptidase",841,2:201266487-201286594,1,2q33-q34,"N, S, F","841,CASP8,ENSG00000064012,Q14790"
CBFA2T3,"core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (MTG-16)",863,16:88876976-88976807,1,16q24,T,"863,CBFA2T3,ENSG00000129993,O75081"
CBFB,"core-binding factor, beta subunit",865,16:67029409-67098733,1,16q22,T,"865,CBFB,ENSG00000067955,Q13951"
CBL,Cas-Br-M (murine) ecotropic retroviral transforming,867,11:119206418-119299781,1,11q23.3,"T, Mis, S, O","867,CBL,CBL2,ENSG00000110395,P22681"
CBLB,Cas-Br-M (murine) ecotropic retroviral transforming sequence b,868,3:105658970-105867577,1,3q13.11,"Mis, S","868,CBLB,ENSG00000114423,Q13191"
CBLC,Cas-Br-M (murine) ecotropic retroviral transforming sequence c,23624,19:44777932-44800443,1,19q13.2,M,"23624,CBLC,ENSG00000142273,Q9ULV8"
CCDC6,coiled-coil domain containing 6,8030,10:59792917-59906424,1,10q21,T,"8030,CCDC6,D10S170,ENSG00000108091,Q16204,TST1"
CCNB1IP1,"cyclin B1 interacting protein 1, E3 ubiquitin protein ligase",57820,14:20311550-20316523,1,14q11.2,T,"57820,C14orf18,CCNB1IP1,ENSG00000100814,Q9NPC3"
CCND1,cyclin D1,595,11:69641314-69651282,1,11q13,T,"595,BCL1,CCND1,D11S287E,ENSG00000110092,P24385,PRAD1"
CCND2,cyclin D2,894,12:4274041-4300009,1,12p13,T,"894,CCND2,ENSG00000118971,P30279"
CCND3,cyclin D3,896,6:41935940-41941649,1,6p21,T,"896,CCND3,ENSG00000112576,P30281"
CCNE1,cyclin E1,898,19:29812556-29823777,1,19q12,A,"898,CCNE,CCNE1,ENSG00000105173,P24864"
CD274,CD274 molecule,29126,9:5456114-5467862,1,9p24,T,"29126,CD274,ENSG00000120217,PDCD1LG1,Q9NZQ7"
CD74,"CD74 molecule, major histocompatibility complex, class II invariant chain",972,5:150402584-150412749,1,5q32,T,"972,CD74,DHLAG,ENSG00000019582,P04233"
CD79A,"CD79a molecule, immunoglobulin-associated alpha",973,19:41877305-41880980,1,19q13.2,S,"973,CD79A,ENSG00000105369,IGA,P11912"
CD79B,"CD79b molecule, immunoglobulin-associated beta",974,17:63929226-63932261,1,17q23,"Mis, S","974,CD79B,ENSG00000007312,IGB,P40259"
CDC73,cell division cycle 73,79577,1:193122201-193250712,1,1q21-q31,"Mis, N, F","79577,C1orf28,CDC73,ENSG00000134371,HRPT1,HRPT2,Q6P1J9"
CDH1,"cadherin 1, type 1, E-cadherin (epithelial) (ECAD)",999,16:68737416-68833499,1,16q22.1,"Mis, N, F, S","999,CDH1,ENSG00000039068,P12830,UVO"
CDH11,"cadherin 11, type 2, OB-cadherin (osteoblast)",1009,16:64947603-65004869,1,16q22.1,T,"1009,CDH11,ENSG00000140937,P55287"
CDK12,cyclin-dependent kinase 12,51755,17:39462072-39531316,1,17q12,"Mis, N, F","51755,CDK12,CRKRS,ENSG00000167258,Q9NYV4"
CDK4,cyclin-dependent kinase 4,1019,12:57748525-57751717,1,12q14,Mis,"1019,CDK4,ENSG00000135446,P11802"
CDK6,cyclin-dependent kinase 6,1021,7:92615140-92833323,1,7q21-q22,T,"1021,CDK6,ENSG00000105810,Q00534"
CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1027,12:12717840-12718946,1,12p13.1-p12,F,"1027,CDKN1B,ENSG00000111276,P46527"
CDKN2A,cyclin-dependent kinase inhibitor 2A (p16(INK4a)) gene,1029,9:21968229-21974827,1,9p21,"D, Mis, N, F, S","1029,CDKN2,CDKN2A,ENSG00000147889,MLM,P42771"
CDKN2C,"cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)",1031,1:50970369-50974270,1,1p32,D,"1031,CDKN2C,ENSG00000123080,P42773"
CDX2,caudal type homeo box transcription factor 2,1045,13:27963115-27969006,1,13q12.3,T,"1045,CDX2,CDX3,ENSG00000165556,Q99626"
CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",1050,19:33301338-33302414,1,19q13.1,"Mis, N, F","1050,CEBP,CEBPA,ENSG00000245848,P49715"
CHCHD7,coiled-coil-helix-coiled-coil-helix domain containing 7,79145,8:56214614-56217435,1,8q11.2,T,"79145,CHCHD7,ENSG00000170791,Q9BUK0"
CHD4,chromodomain helicase DNA binding protein 4,1108,12:6570676-6606373,1,12p13,"Mis, F, N","1108,CHD4,ENSG00000111642,Q14839"
CHEK2,CHK2 checkpoint homolog (S. pombe),11200,22:28687897-28734721,1,22q12.1,F,"11200,CHEK2,ENSG00000183765,O96017,RAD53"
CIC,capicua homolog,23152,19:42284705-42295191,1,19q13.2,"Mis, F, S,T","23152,CIC,ENSG00000079432"
CIITA,"class II, major histocompatibility complex, transactivator",4261,16:10877332-10923304,1,16p13,T,"4261,CIITA,ENSG00000179583,MHC2TA,P33076"
CLIP1,CAP-GLY domain containing linker protein 1,6249,12:122272875-122380452,1,12q24.3,T,"6249,CLIP1,ENSG00000130779,P30622,RSN"
CLTC,"clathrin, heavy polypeptide (Hc)",1213,17:59620133-59693853,1,17q11-qter,T,"1213,CLTC,CLTCL2,ENSG00000141367,Q00610"
CLTCL1,"clathrin, heavy polypeptide-like 1",8218,22:19180219-19291641,1,22q11.21,T,"8218,CLTCL,CLTCL1,ENSG00000070371,P53675"
CNBP,"CCHC-type zinc finger, nucleic acid binding protein",7555,3:129170453-129171757,1,3q21,T,"7555,CNBP,DM2,ENSG00000169714,P62633,ZNF9"
CNOT3,CCR4-NOT transcription complex subunit 3,4849,19:54142979-54155407,1,19q13.4,"Mis, N, F","4849,CNOT3,ENSG00000088038,NOT3,O75175"
CNTRL,centriolin,11064,9:121088328-121177187,1,9q33.2,T,"11064,CEP1,CEP110,CNTRL,ENSG00000119397,Q7Z7A1"
COL1A1,"collagen, type I, alpha 1",1277,17:50185502-50201513,1,17q21.31-q22,T,"1277,COL1A1,ENSG00000108821,P02452"
COL2A1,"collagen, type II, alpha 1",1280,12:47973407-48004321,1,12q13.11,"F, Mis, N, T","1280,AOM,COL2A1,ENSG00000139219,P02458,SEDC"
CREB1,cAMP responsive element binding protein 1,1385,2:207555637-207597059,1,2q34,T,"1385,CREB1,ENSG00000118260,P16220"
CREB3L1,cAMP responsive element binding protein 3-like 1,90993,11:46278112-46320746,1,11p11.2,T,"90993,CREB3L1,ENSG00000157613,Q96BA8"
CREB3L2,cAMP responsive element binding protein 3-like 2,64764,7:137880476-138001705,1,7q34,T,"64764,CREB3L2,ENSG00000182158,Q70SY1"
CREBBP,CREB binding protein (CBP),1387,16:3727718-3879916,1,16p13.3,"T, N, F, Mis, O","1387,CREBBP,ENSG00000005339,Q92793,RSTS"
CRLF2,cytokine receptor-like factor 2,64109,"X,Y:1196780-1212634",1,"Xp22.3; Yp11.3","Mis, T","64109,CRLF2,ENSG00000205755"
CRTC1,CREB regulated transcription coactivator 1,23373,19:18683703-18777382,1,19p13.11,T,"23373,CRTC1,ENSG00000105662,MECT1,Q6UUV9"
CRTC3,CREB regulated transcription coactivator 3,64784,15:90530072-90642140,1,15q26.1,T,"64784,CRTC3,ENSG00000140577,Q6UUV7"
CSF3R,colony stimulating factor 3 receptor (granulocyte),1441,1:36466357-36479496,1,1p35-p34.4,"Mis, N","1441,CD114,CSF3R,ENSG00000119535,Q99062"
CTCF,CCCTC-binding factor,10664,16:67610833-67637872,1,16q22.1,"Mis, N","10664,CTCF,ENSG00000102974,P49711"
CTNNB1,"catenin (cadherin-associated protein), beta 1",1499,3:41224069-41239342,1,3p22-p21.3,"Mis, O, T","1499,CTNNB,CTNNB1,ENSG00000168036,P35222"
CUX1,cut-like homeobox 1,1523,7:101817640-102249042,1,7q22.1,"N,F,S,Mis,O,T","1523,CUTL1,CUX1,ENSG00000257923,P39880"
CXCR4,C-X-C motif chemokine receptor 4,7852,2:136114869-136115939,1,2q21,"Mis, N, F","7852,CXCR4,ENSG00000121966,P61073"
CYLD,familial cylindromatosis gene,1540,16:50749699-50796508,1,16q12-q13,"Mis, N, F, S","1540,CYLD,CYLD1,ENSG00000083799,Q9NQC7"
DAXX,death-domain associated protein,1616,6:33318743-33321925,1,6p21.3,"Mis, F, N","1616,DAXX,ENSG00000204209,Q9UER7"
DCTN1,dynactin 1,1639,2:74361499-74380037,1,2p13,T,"1639,DCTN1,ENSG00000204843,Q14203"
DDB2,damage-specific DNA binding protein 2,1643,11:47215137-47238849,1,11p12,"Mis, N","1643,DDB2,ENSG00000134574,Q92466"
DDIT3,DNA-damage-inducible transcript 3,1649,12:57516809-57517406,1,12q13.1-q13.2,T,"1649,DDIT3,ENSG00000175197,P35638"
DDR2,discoidin domain receptor 2,4921,1:162719064-162780246,1,1q12-q23,"Mis, N","4921,DDR2,ENSG00000162733,NTRKR3,Q16832,TYRO10"
DDX10,DEAD (Asp-Glu-Ala-Asp) box polypeptide 10,1662,11:108665154-108940423,1,11q22-q23,T,"1662,DDX10,ENSG00000178105,Q13206"
DDX3X,"DEAD-box helicase 3, X-linked",1654,X:41334253-41347719,1,Xp11.4,"Mis, N, F","1654,DDX3,DDX3X,ENSG00000215301,O00571"
DDX5,DEAD (Asp-Glu-Ala-Asp) box polypeptide 5,1655,17:64499923-64506119,1,17q21,T,"1655,DDX5,ENSG00000108654,G17P1,HLR1,P17844"
DDX6,DEAD (Asp-Glu-Ala-Asp) box polypeptide 6,1656,11:118754712-118786218,1,11q23.3,T,"1656,DDX6,ENSG00000110367,HLR2,P26196"
DEK,DEK oncogene (DNA binding),7913,6:18225719-18263987,1,6p23,T,"7913,DEK,ENSG00000124795,P35659"
DICER1,"dicer 1, ribonuclease type III",23405,14:95090498-95133458,1,14q32.13,"Mis, F, N","23405,DICER1,ENSG00000100697,MNG1,Q9UPY3"
DNAJB1,DnaJ heat shock protein family (Hsp40) member B1,3337,19:14515940-14518349,1,19p13.2,T,"3337,DNAJB1,ENSG00000132002,HSPF1,P25685"
DNM2,dynamin 2,1785,19:10718243-10831047,1,19p13.2,"F, N, S, Mis, O","1785,DNM2,ENSG00000079805,P50570"
DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,1788,2:25234279-25313984,1,2p23,"Mis, F, N, S","1788,DNMT3A,ENSG00000119772,Q9Y6K1"
DROSHA,drosha ribonuclease III,29102,5:31401432-31529059,1,5q11.2,"A, Mis, N, F","29102,DROSHA,ENSG00000113360,Q9NRR4,RNASEN"
EBF1,early B-cell factor 1,1879,5:158699111-159099478,1,5q34,T,"1879,EBF,EBF1,ENSG00000164330,Q9UH73"
EGFR,"epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)",1956,7:55019278-55205617,1,7p12.3-p12.1,"A, O, Mis","1956,EGFR,ENSG00000146648,ERBB,P00533"
EIF3E,"eukaryotic translation initiation factor 3, subunit E",3646,8:108201885-108248702,1,8q22-q23,T,"3646,EIF3E,EIF3S6,ENSG00000104408,INT6,P60228"
EIF4A2,"eukaryotic translation initiation factor 4A, isoform 2",1974,3:186783611-186789269,1,3q27.3,T,"1974,EIF4A2,EIF4F,ENSG00000156976,Q14240"
ELF4,E74-like factor 4 (ets domain transcription factor),2000,X:130066721-130081330,1,Xq26,T,"2000,ELF4,ENSG00000102034,Q99607"
ELK4,"ELK4, ETS-domain protein (SRF accessory protein 1)",2005,1:205616546-205623882,1,1q32,T,"2005,ELK4,ENSG00000158711,P28324"
ELL,ELL gene (11-19 lysine-rich leukemia gene),8178,19:18444752-18522055,1,19p13.1,T,"8178,C19orf17,ELL,ENSG00000105656,P55199"
EML4,echinoderm microtubule associated protein like 4,27436,2:42169613-42330208,1,2p21,T,"27436,C2orf2,EML4,ENSG00000143924,Q9HC35"
EP300,300 kd E1A-Binding protein gene,2033,22:41093005-41178956,1,22q13,"T,  N, F, Mis, O","2033,ENSG00000100393,EP300,Q09472"
EPAS1,endothelial PAS domain protein 1,2034,2:46297912-46384660,1,2p21-p16,Mis,"2034,ENSG00000116016,EPAS1,Q99814"
EPS15,epidermal growth factor receptor pathway substrate 15 (AF1p),2060,1:51356700-51519231,1,1p32,T,"2060,ENSG00000085832,EPS15,P42566"
ERBB2,"v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)",2064,17:39700239-39728044,1,17q21.1,"A, Mis, O","2064,ENSG00000141736,ERBB2,HER2,NGL,P04626"
ERBB3,erb-b2 receptor tyrosine kinase 3,2065,12:56080301-56102055,1,12q13,"Mis, N","2065,ENSG00000065361,ERBB3,LCCS2,P21860"
ERBB4,erb-b2 receptor tyrosine kinase 4,2066,2:211383615-212538530,1,2q33.3-q34,"Mis, N","2066,ENSG00000178568,ERBB4,Q15303"
ERC1,ELKS/RAB6-interacting/CAST family member 1,23085,12:1027904-1490230,1,12p13.3,T,"23085,ENSG00000082805,ERC1,Q8IUD2,RAB6IP2"
ERCC2,"excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D)",2068,19:45351629-45370237,1,19q13.2-q13.3,"Mis, N, F, S","2068,ENSG00000104884,ERCC2,P18074,XPD"
ERCC3,"excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)",2071,2:127257596-127294081,1,2q21,"Mis, S","2071,ENSG00000163161,ERCC3,P19447"
ERCC4,"excision repair cross-complementing rodent repair deficiency, complementation group 4",2072,16:13920166-13948347,1,16p13.3-p13.13,"Mis, N, F","2072,ENSG00000175595,ERCC4,Q92889,XPF"
ERCC5,"excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome))",2073,13:102846267-102875903,1,13q33,"Mis, N, F","2073,ENSG00000134899,ERCC5,ERCM2,P28715,XPGC"
ERG,v-ets erythroblastosis virus E26 oncogene like (avian),2078,21:38383403-38575700,1,21q22.3,"T, A","2078,ENSG00000157554,ERG,P11308"
ESR1,estrogen receptor 1,2099,6:151807913-152098966,1,6q25.1,Mis,"2099,ENSG00000091831,ESR,ESR1,P03372"
ETNK1,ethanolamine kinase 1,55500,12:22625164-22684954,1,12p12.1,Mis,"55500,ENSG00000139163,ETNK1,Q9HBU6"
ETV1,ets variant gene 1,2115,7:13895866-13989052,1,7p22,T,"2115,ENSG00000006468,ETV1,P50549"
ETV4,"ets variant gene 4 (E1A enhancer binding protein, E1AF)",2118,17:43528519-43545617,1,17q21,T,"2118,ENSG00000175832,ETV4,P43268"
ETV5,ets variant gene 5,2119,3:186048639-186105868,1,3q28,T,"2119,ENSG00000244405,ETV5,P41161"
ETV6,ets variant gene 6 (TEL oncogene),2120,12:11650128-11891046,1,12p13,T,"2120,ENSG00000139083,ETV6,P41212"
EWSR1,Ewing sarcoma breakpoint region 1 (EWS),2130,22:29268337-29300161,1,22q12,T,"2130,ENSG00000182944,EWSR1,Q01844"
EXT1,multiple exostoses type 1 gene,2131,8:117799712-118111046,1,8q24.11-q24.13,"Mis, N, F, S","2131,ENSG00000182197,EXT1,LGCR,LGS,Q16394"
EXT2,multiple exostoses type 2 gene,2132,11:44107713-44244287,1,11p12-p11,"Mis, N, F, S","2132,ENSG00000151348,EXT2,Q93063"
EZH2,enhancer of zeste homolog 2,2146,7:148807646-148847298,1,7q35-q36,Mis,"2146,ENSG00000106462,EZH2,Q15910"
EZR,ezrin,7430,6:158766914-158818093,1,6q25.3,T,"7430,ENSG00000092820,EZR,P15311,VIL2"
FAM46C,"family with sequence similarity 46, member C",54855,1:117622869-117624044,1,1p12,"Mis, F, O","54855,ENSG00000183508,FAM46C,Q5VWP2"
FANCA,"Fanconi anemia, complementation group A",2175,16:89738601-89816615,1,16q24.3,"D, Mis, N, F, S","2175,ENSG00000187741,FACA,FANCA,FANCH,O15360"
FANCC,"Fanconi anemia, complementation group C",2176,9:95101707-95249291,1,9q22.3,"D, Mis, N, F, S","2176,ENSG00000158169,FACC,FANCC,Q00597"
FANCD2,"Fanconi anemia, complementation group D2",2177,3:10028658-10098950,1,3p26,"D, Mis, N, F","2177,ENSG00000144554,FACD,FANCD,FANCD2,Q9BXW9"
FANCE,"Fanconi anemia, complementation group E",2178,6:35452546-35466345,1,6p21-p22,"N, F, S","2178,ENSG00000112039,FACE,FANCE,Q9HB96"
FANCF,"Fanconi anemia, complementation group F",2188,11:22624686-22625810,1,11p15,"N, F","2188,ENSG00000183161,FANCF,Q9NPI8"
FANCG,"Fanconi anemia, complementation group G",2189,9:35074108-35079524,1,9p13,"Mis, N, F, S","2189,ENSG00000221829,FANCG,O15287,XRCC9"
FAS,Fas cell surface death receptor,355,10:88990877-89014450,1,10q24.1,Mis,"355,ALPS1A,APO-1,APT1,CD95,ENSG00000026103,FAS,FAS1,FASTM,P25445,TNFRSF6"
FAT1,FAT atypical cadherin 1,2195,4:186588592-186709827,1,4q35.2,"Mis, N, F, S","2195,ENSG00000083857,FAT,FAT1,Q14517"
FAT4,FAT atypical cadherin 4,79633,4:125316412-125491768,1,4q28.1,"Mis, N","79633,ENSG00000196159,FAT4"
FBXO11,F-box protein 11,80204,2:47808118-47839749,1,2p16.3,"Mis, F, D","80204,ENSG00000138081,FBXO11,Q86XK2"
FBXW7,"F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)",55294,4:152322881-152411803,1,4q31.3,"Mis, N, D, F","55294,ENSG00000109670,FBXW7,Q969H0"
FCGR2B,"Fc fragment of IgG, low affinity IIb, receptor for (CD32)",2213,1:161663242-161677553,1,1q23,T,"2213,ENSG00000072694,FCG2,FCGR2,FCGR2B,P31994"
FCRL4,Fc receptor-like 4,83417,1:157575524-157597944,1,1q21,T,"83417,ENSG00000163518,FCRL4,Q96PJ5"
FES,"FES proto-oncogene, tyrosine kinase",2242,15:90885046-90895558,1,15q26.1,"Mis, F","2242,ENSG00000182511,FES,P07332"
FEV,FEV protein - (HSRNAFEV),54738,2:218981667-218985075,1,2q36,T,"54738,ENSG00000163497,FEV,Q99581"
FGFR1,fibroblast growth factor receptor 1,2260,8:38413628-38457446,1,8p11.2-p11.1,T,"2260,ENSG00000077782,FGFR1,FLT2,KAL2,P11362"
FGFR1OP,FGFR1 oncogene partner (FOP),11116,6:166999414-167039979,1,6q27,T,"11116,ENSG00000213066,FGFR1OP,O95684"
FGFR2,fibroblast growth factor receptor 2,2263,10:121479857-121593817,1,10q26,Mis,"2263,BEK,CFD1,ENSG00000066468,FGFR2,JWS,KGFR,P21802"
FGFR3,fibroblast growth factor receptor 3,2261,4:1793935-1807262,1,4p16.3,"Mis, T","2261,ACH,ENSG00000068078,FGFR3,P22607"
FGFR4,fibroblast growth factor receptor 4,2264,5:177089603-177097676,1,5q35.2,Mis,"2264,ENSG00000160867,FGFR4,P22455"
FH,fumarate hydratase,2271,1:241497828-241519722,1,1q42.1,"Mis, N, F","2271,ENSG00000091483,FH,P07954"
FHIT,fragile histidine triad gene,2272,3:59752226-60536962,1,3p14.2,T,"2272,ENSG00000189283,FHIT,P49789"
FIP1L1,FIP1 like 1 (S. cerevisiae),81608,4:53377840-53459450,1,4q12,T,"81608,ENSG00000145216,FIP1L1,Q6UN15"
FLCN,folliculin,201163,17:17213655-17228137,1,17p11.2,"Mis. N, F","201163,ENSG00000154803,FLCN,Q8NFG4"
FLI1,Friend leukemia virus integration 1,2313,11:128694259-128810988,1,11q24,T,"2313,ENSG00000151702,FLI1,Q01543"
FLT3,fms-related tyrosine kinase 3,2322,13:28004052-28100510,1,13q12,"Mis, O","2322,ENSG00000122025,FLT3,P36888"
FLT4,fms-related tyrosine kinase 4,2324,5:180608281-180649545,1,5q35.3,A,"2324,ENSG00000037280,FLT4,P35916"
FOXA1,forkhead box A1,3169,14:37591365-37594972,1,14q12-q13,"Mis, F","3169,ENSG00000129514,FOXA1,HNF3A,P55317"
FOXL2,forkhead box L2,668,3:138945592-138946722,1,3q23,Mis,"668,BPES,ENSG00000183770,FOXL2,P58012"
FOXO1,forkhead box O1,2308,13:40555680-40666212,1,13q14.1,T,"2308,ENSG00000150907,FKHR,FOXO1,FOXO1A,Q12778"
FOXO3,forkhead box O3,2309,6:108561209-108664855,1,6q21,T,"2309,ENSG00000118689,FKHRL1,FOXO3,FOXO3A,O43524"
FOXO4,forkhead box O4,4303,X:71096529-71102084,1,Xq13.1,T,"4303,ENSG00000184481,FOXO4,MLLT7,P98177"
FOXP1,forkhead box P1,27086,3:70959247-71198381,1,3p14.1,T,"27086,ENSG00000114861,FOXP1,Q9H334"
FSTL3,follistatin-like 3 (secreted glycoprotein),10272,19:676425-681709,1,19p13,T,"10272,ENSG00000070404,FSTL3,O95633"
FUBP1,far upstream element (FUSE) binding protein 1,8880,1:77949146-77979004,1,1p13.1,"F, N","8880,ENSG00000162613,FUBP,FUBP1,Q96AE4"
FUS,"fusion, derived from t(12;16) malignant liposarcoma",2521,16:31180215-31191438,1,16p11.2,T,"2521,ALS6,ENSG00000089280,FUS,P35637"
GAS7,growth arrest-specific 7,8522,17:9917228-10198390,1,17p,T,"8522,ENSG00000007237,GAS7,O60861"
GATA1,GATA binding protein 1 (globin transcription factor 1),2623,X:48791110-48794164,1,Xp11.23,"Mis, F","2623,ENSG00000102145,GATA1,GF1,P15976"
GATA2,GATA binding protein 2,2624,3:128481019-128487031,1,3q21.3,Mis,"2624,ENSG00000179348,GATA2,P23769"
GATA3,GATA binding protein 3,2625,10:8055656-8074023,1,10p15,"F, N, S","2625,ENSG00000107485,GATA3,P23771"
GNA11,"guanine nucleotide binding protein (G protein), alpha 11 (Gq class)",2767,19:3094652-3121179,1,19p13.3,Mis,"2767,ENSG00000088256,GNA11,HHC2,P29992"
GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",2776,9:77721323-78031235,1,9q21,Mis,"2776,ENSG00000156052,GNAQ,P50148"
GNAS,"guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1",2778,20:58891727-58910829,1,20q13.2,Mis,"2778,ENSG00000087460,GNAS,GNAS1,P63092"
GOLGA5,"golgi autoantigen, golgin subfamily a, 5  (PTC5)",9950,14:92797439-92839447,1,14q,T,"9950,ENSG00000066455,GOLGA5,Q8TBA6"
GOPC,golgi associated PDZ and coiled-coil motif containing,57120,6:117563254-117602288,1,6q21,T,"57120,ENSG00000047932,GOPC,Q9HD26"
GPC3,glypican 3,2719,X:133536124-133985449,1,Xq26.1,"D, Mis, N, F, S","2719,ENSG00000147257,GPC3,P51654,SDYS"
GPHN,gephyrin (GPH),10243,14:66508529-67180938,1,14q24,T,"10243,ENSG00000171723,GPHN,Q9NQX3"
GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",2903,16:9763149-10180411,1,16p13.2,"Mis, N, F, O","2903,ENSG00000183454,GRIN2A,NMDAR2A,Q12879"
H3F3A,"H3 histone, family 3A",3020,1:226064352-226071479,1,1q42.12,Mis,"3020,ENSG00000163041,H3F3,H3F3A,P84243"
H3F3B,"H3 histone, family 3B (H3.3B)",3021,17:75778595-75779174,1,17q25.1,Mis,"3020,ENSG00000132475,H3F3B,P84243"
HERPUD1,"homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1",9709,16:56932245-56943290,1,16q12.2-q13,T,"9709,ENSG00000051108,HERPUD1,Q15011"
HEY1,hairy/enhancer-of-split related with YRPW motif 1,23462,8:79765188-79767663,1,8q21,T,"23462,ENSG00000164683,HEY1,Q9Y5J3"
HIF1A,hypoxia inducible factor 1 alpha subunit,3091,14:61695805-61747085,1,14q23.2,"Mis, F, N","3091,ENSG00000100644,HIF1A,Q16665"
HIP1,huntingtin interacting protein 1,3092,7:75538172-75738920,1,7q11.23,T,"3092,ENSG00000127946,HIP1,O00291"
HIST1H3B,"histone cluster 1, H3b",8358,6:26031650-26032060,1,6p22.1,Mis,"8350,ENSG00000124693,H3FL,HIST1H3B,P68431"
HIST1H4I,"histone 1, H4i (H4FM)",8294,6:27107089-27107660,1,6p21.3,T,
HLA-A,"major histocompatibility complex, class I, A",3105,6:29942554-29945455,1,6p21.3,T,"3105,ENSG00000206503,HLA-A,P04439"
HLF,hepatic leukemia factor,3131,17:55265486-55320880,1,17q22,T,"3131,ENSG00000108924,HLF,Q16534"
HMGA1,high mobility group AT-hook 1,3159,6:34240781-34244884,1,6p21,T,"3159,ENSG00000137309,HMGA1,HMGIY,P17096"
HMGA2,high mobility group AT-hook 2 (HMGIC),8091,12:65825271-65963292,1,12q15,T,"8091,ENSG00000149948,HMGA2,HMGIC,P52926"
HNF1A,HNF1 homeobox A,6927,12:120978769-121001192,1,12q24.2,"Mis, F","6927,ENSG00000135100,HNF1A,MODY3,TCF1"
HNRNPA2B1,heterogeneous nuclear ribonucleoprotein A2/B1,3181,7:26190125-26200577,1,7p15,T,"3181,ENSG00000122566,HNRNPA2B1,HNRPA2B1,P22626"
HOOK3,hook homolog 3,84376,8:42897132-43018498,1,8p11.21,T,"84376,ENSG00000168172,HOOK3,Q86VS8"
HOXA11,homeo box A11,3207,7:27182796-27185144,1,7p15-p14.2,T,"3207,ENSG00000005073,HOX1,HOX1I,HOXA11,P31270"
HOXA13,homeo box A13,3209,7:27198198-27200077,1,7p15-p14.2,T,"3209,ENSG00000106031,HOX1,HOX1J,HOXA13,P31271"
HOXA9,homeo box A9,3205,7:27163603-27165457,1,7p15-p14.2,T,"3205,ENSG00000078399,HOX1,HOX1G,HOXA9,P31269"
HOXC11,homeo box C11,3227,12:53973243-53975414,1,12q13.3,T,"3227,ENSG00000123388,HOX3H,HOXC11,O43248"
HOXC13,homeo box C13,3229,12:53938908-53945257,1,12q13.3,T,"3229,ENSG00000123364,HOX3,HOX3G,HOXC13,P31276"
HOXD11,homeo box D11,3237,2:176107357-176109143,1,2q31-q32,T,"3237,ENSG00000128713,HOX4,HOX4F,HOXD11,P31277"
HOXD13,homeo box D13,3239,2:176092916-176094731,1,2q31-q32,T,"3239,HOX4I,HOXD13,P35453,SPD"
HRAS,v-Ha-ras Harvey rat sarcoma viral oncogene homolog,3265,11:532636-534322,1,11p15.5,Mis,"3265,ENSG00000174775,HRAS,HRAS1,P01112"
HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",3320,14:102081712-102139404,1,14q32.33,T,"3320,ENSG00000080824,HSP90AA1,HSPC1,HSPCA,P07900"
HSP90AB1,"heat shock protein 90kDa alpha (cytosolic), class B member 1",3326,6:44248630-44253598,1,6p12,T,"3326,ENSG00000096384,HSP90AB1,HSPC2,HSPCB,P08238"
IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",3417,2:208237079-208251551,1,2q33.3,Mis,"3417,ENSG00000138413,IDH1,O75874"
IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",3418,15:90084266-90102390,1,15q26.1,Mis,"3418,ENSG00000182054,IDH2,P48735"
IGH,immunoglobulin heavy locus,3492,14:-,1,14q32.33,T,
IGK,immunoglobulin kappa locus,50802,2:-,1,2p12,T,
IGL,immunoglobulin lambda locus,3535,22:-,1,22q11.2,T,
IKBKB,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta",3551,8:42272100-42330979,1,8p11.2,Mis,"3551,ENSG00000104365,IKBKB,O14920"
IKZF1,IKAROS family zinc finger 1,10320,7:50319062-50400628,1,7p12.2,"D,T","10320,ENSG00000185811,IKZF1,Q13422,ZNFN1A1"
IL2,interleukin 2,3558,4:122451752-122456440,1,4q26-q27,T,"3558,ENSG00000109471,IL2,P60568"
IL21R,interleukin 21 receptor,50615,16:27430073-27449284,1,16p11,T,"50615,ENSG00000103522,IL21R,Q9HBE5"
IL6ST,"interleukin 6 signal transducer (gp130, oncostatin M receptor)",3572,5:55941082-55976278,1,5q11,O,"3572,ENSG00000134352,IL6ST,P40189"
IL7R,interleukin 7 receptor,3575,5:35856978-35876486,1,5p13,"Mis, O","3575,ENSG00000168685,IL7R,P16871"
IRF4,interferon regulatory factor 4,3662,6:393154-407599,1,6p25-p23,T,"3662,ENSG00000137265,IRF4,MUM1,Q15306"
IRS4,insulin receptor substrate 4,8471,X:108732571-108736344,1,Xq22.3,"Mis, F, T","8471,ENSG00000133124,IRS4,O14654"
ITK,IL2-inducible T-cell kinase,3702,5:157180978-157252678,1,5q31-q32,T,"3702,ENSG00000113263,ITK,Q08881"
JAK1,Janus kinase 1,3716,1:64834562-64886264,1,1p32.3-p31.3,Mis,"3716,ENSG00000162434,JAK1,JAK1B,P23458"
JAK2,Janus kinase 2,3717,9:5021988-5126791,1,9p24,"T, Mis, O","3717,ENSG00000096968,JAK2,O60674"
JAK3,Janus kinase 3,3718,19:17826743-17844417,1,19p13.1,Mis,"3718,ENSG00000105639,JAK3,P52333"
JUN,jun oncogene,3725,1:58782075-58783070,1,1p32-p31,A,"3725,ENSG00000177606,JUN,P05412"
KAT6A,K(lysine) acetyltransferase 6A,7994,8:-,1,8p11,"T, A",
KAT6B,K(lysine) acetyltransferase 6B,23522,10:74842858-75031046,1,10q22.2,T,"23522,ENSG00000156650,KAT6B,MYST4,Q8WYB5"
KCNJ5,"potassium inwardly-rectifying channel; subfamily J; member 5",3762,11:128911274-128916731,1,11q24,Mis,"3762,ENSG00000120457,KCNJ5,P48544"
KDM5A,"lysine (K)-specific demethylase 5A, JARID1A",5927,12:285456-389091,1,12p11,T,"5927,ENSG00000073614,JARID1A,KDM5A,RBBP2"
KDM5C,lysine (K)-specific demethylase 5C (JARID1C),8242,X:53192967-53224889,1,Xp11.22-p11.21,"N, F, S, Mis","8242,ENSG00000126012,JARID1C,KDM5C,MRX13,P41229,SMCX"
KDM6A,"lysine (K)-specific demethylase 6A, UTX",7403,X:44873552-45111411,1,Xp11.2,"D, N, F, S","7403,ENSG00000147050,KDM6A,O15550,UTX"
KDR,vascular endothelial growth factor receptor 2,3791,4:55079941-55125293,1,4q11-q12,Mis,"3791,ENSG00000128052,KDR,P35968"
KDSR,3-ketodihydrosphingosine reductase,2531,18:63331782-63367118,1,18q21.3,T,"2531,ENSG00000119537,FVT1,KDSR,Q06136"
KEAP1,kelch like ECH associated protein 1,9817,19:10486652-10500033,1,19p13.2,"Mis, N, F","9817,ENSG00000079999,KEAP1,Q14145"
KIF5B,kinesin family member 5B,3799,10:32009010-32055973,1,10p11.22,T,"3799,ENSG00000170759,KIF5B,KNS1,P33176"
KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,3815,4:54658015-54738557,1,4q12,"Mis, O","3815,ENSG00000157404,KIT,P10721,PBT"
KLF4,Kruppel-like factor 4,9314,9:107485751-107489172,1,9q31,Mis,"9314,ENSG00000136826,KLF4,O43474"
KLF6,Kruppel-like factor 6,1316,10:3779539-3785014,1,10p15,"Mis, N","1316,BCD1,COPEB,ENSG00000067082,KLF6,Q99612,ST12"
KLK2,kallikrein-related peptidase 2,3817,19:50873474-50878559,1,19q13.41,T,"3817,ENSG00000167751,KLK2,P20151"
KMT2A,lysine (K)-specific methyltransferase 2A,4297,11:118436513-118522172,1,11q23,"T, O","4297,ENSG00000118058,KMT2A,MLL,Q03164"
KMT2C,lysine (K)-specific methyltransferase 2C,58508,7:152136832-152435786,1,7q36.1,N,"58508,ENSG00000055609,KMT2C,MLL3,Q8NEZ4"
KMT2D,lysine (K)-specific methyltransferase 2D,8085,12:49021780-49055324,1,12q13.12,"N, F, Mis","8085,ENSG00000167548,KMT2D,MLL2,O14686,TNRC21"
KRAS,v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog,3845,12:25209795-25245384,1,12p12.1,Mis,"3845,ENSG00000133703,KRAS,KRAS2,P01116"
KTN1,kinectin 1 (kinesin receptor),3895,14:55612050-55680691,1,14q22.1,T,"3895,ENSG00000126777,KTN1,Q86UP2"
LASP1,LIM and SH3 protein 1,3927,17:38870190-38918778,1,17q11-q21.3,T,"3927,ENSG00000002834,LASP1,Q14847"
LCK,lymphocyte-specific protein tyrosine kinase,3932,1:32274330-32285716,1,1p35-p34.3,T,"3932,ENSG00000182866,LCK,P06239"
LEF1,lymphoid enhancer binding factor 1,51176,4:108063629-108167767,1,4q25,"Mis, N","51176,ENSG00000138795,LEF1,Q9UJU2"
LIFR,leukemia inhibitory factor receptor,3977,5:38481595-38530647,1,5p13-p12,T,"3977,ENSG00000113594,LIFR,P42702"
LMNA,lamin A/C,4000,1:156114919-156139106,1,1q22,T,"4000,CMD1A,ENSG00000160789,LGMD1B,LMN1,LMNA,LMNL1,P02545,PRO1"
LMO1,LIM domain only 1 (rhombotin 1) (RBTN1),4004,11:8224616-8268634,1,11p15,"T, A","4004,ENSG00000166407,LMO1,P25800,RBTN1"
LMO2,LIM domain only 2 (rhombotin-like 1) (RBTN2),4005,11:33859356-33869386,1,11p13,T,"4005,ENSG00000135363,LMO2,P25791,RBTNL1"
LPP,LIM domain containing preferred translocation partner in lipoma,4026,3:188406122-188874480,1,3q28,T,"4026,ENSG00000145012,LPP,Q93052"
LRIG3,leucine-rich repeats and immunoglobulin-like domains 3,121227,12:58872572-58920235,1,12q14.1,T,"121227,ENSG00000139263,LRIG3,Q6UXM1"
LRP1B,LDL receptor related protein 1B,53353,2:140233186-142130729,1,2q21.2,"D, Mis, N, F","53353,ENSG00000168702,LRP1B,Q9NZR2"
LYL1,lymphoblastic leukemia derived sequence 1,4066,19:13099319-13101171,1,19p13.2-p13.1,T,"4066,ENSG00000104903,LYL1,P12980"
LZTR1,leucine-zipper-like transcription regulator 1,8216,22:20982372-20997348,1,22q11.21,"Mis, F, N","8216,ENSG00000099949,LZTR1,Q8N653"
MAF,v-maf musculoaponeurotic fibrosarcoma oncogene homolog,4094,16:79594460-79599902,1,16q22-q23,T,"4094,ENSG00000178573,MAF,O75444"
MAFB,v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian),9935,20:40687879-40688850,1,20q11.2-q13.1,T,"9935,ENSG00000204103,KRML,MAFB,Q9Y5Q3"
MALT1,mucosa associated lymphoid tissue lymphoma translocation gene 1,10892,18:58671645-58747843,1,18q21,T,"10892,ENSG00000172175,MALT1,MLT,Q9UDY8"
MAML2,mastermind-like 2 (Drosophila),84441,11:95978948-96341895,1,11q22-q23,T,"84441,ENSG00000184384,MAML2,Q8IZL2"
MAP2K1,mitogen-activated protein kinase kinase 1,5604,15:66387348-66490615,1,15q22.1-q22.33,Mis,"5604,ENSG00000169032,MAP2K1,PRKMK1,Q02750"
MAP2K2,mitogen-activated protein kinase kinase 2,5605,19:4090598-4123875,1,19p13.3,Mis,"5605,ENSG00000126934,MAP2K2,P36507,PRKMK2"
MAP2K4,mitogen-activated protein kinase kinase 4,6416,17:12020887-12141260,1,17p11.2,"D, Mis, N","6416,ENSG00000065559,MAP2K4,P45985,SERK1"
MAP3K1,"mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase",4214,5:56152434-56189507,1,5q11.2,"N, F, Mis, O, S",
MAP3K13,mitogen-activated protein kinase kinase kinase 13,9175,3:185428582-185482456,1,3q27,F,"9175,ENSG00000073803,MAP3K13,O43283"
MAPK1,mitogen-activated protein kinase 1,5594,22:21769204-21867440,1,22q11.2,Mis,"5594,ENSG00000100030,MAPK1,P28482,PRKM1,PRKM2"
MAX,Myc associated factor X,4149,14:65076476-65102339,1,14q23,"Mis, N, F","10344,4149,CCL26,ENSG00000006606,ENSG00000125952,MAX,P61244,Q9Y258,SCYA26"
MDM2,Mdm2 p53 binding protein homolog,4193,12:68808478-68839849,1,12q15,A,"4193,ENSG00000135679,MDM2,Q00987"
MDM4,Mdm4 p53 binding protein homolog,4194,1:204525519-204549682,1,1q32,A,"4194,ENSG00000198625,MDM4,O15151"
MECOM,MDS1 and EVI1 complex locus,2122,3:169084909-169131477,1,3q26.2,T,"2122,ENSG00000085276,EVI1,MDS1,MECOM,Q03112"
MED12,mediator complex subunit 12,9968,X:71118755-71142218,1,Xq13,"Mis, S, O","9968,ENSG00000184634,FGS1,MED12,Q93074,TNRC11"
MEN1,multiple endocrine neoplasia type 1 gene,4221,11:64804334-64810109,1,11q13,"D, Mis, N, F, S","4221,ENSG00000133895,MEN1,O00255"
MET,met proto-oncogene (hepatocyte growth factor receptor),4233,7:116699085-116796124,1,7q31,Mis,"4233,ENSG00000105976,MET,P08581"
MITF,melanogenesis-associated transcription factor,4286,3:69936723-69965248,1,3p14.1,A,"4286,ENSG00000187098,MITF,O75030,WS2,WS2A"
MKL1,megakaryoblastic leukemia (translocation) 1,57591,22:40411390-40463227,1,22q13,T,"57591,ENSG00000196588,MKL1,Q969V6"
MLF1,myeloid leukemia factor 1,4291,3:158571302-158605203,1,3q25.1,T,"4291,ENSG00000178053,MLF1,P58340"
MLH1,E.coli MutL homolog gene,4292,3:36993548-37050653,1,3p21.3,"D, Mis, N, F, S","4292,COCA2,ENSG00000076242,MLH1,P40692"
MLLT1,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 (ENL)",4298,19:6213042-6279784,1,19p13.3,T,"4298,ENSG00000130382,MLLT1,Q03111"
MLLT10,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (AF10)",8028,10:21534646-21740235,1,10p12,T,"8028,ENSG00000078403,MLLT10,P55197"
MLLT11,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11",10962,1:151039702-151040970,1,1q21,T,"10962,ENSG00000213190,MLLT11,Q13015"
MLLT3,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (AF9)",4300,9:20346443-20622256,1,9p22,T,"4300,ENSG00000171843,MLLT3,P42568"
MLLT4,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (AF6)",4301,6:167827134-167952263,1,6q27,T,
MLLT6,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 (AF17)",4302,17:36861887-36881852,1,17q21,T,"4302,ENSG00000108292,MLLT6,P55198"
MN1,"MN1 proto-oncogene, transcriptional regulator",4330,22:27750915-27800543,1,22q12.1,T,"4330,ENSG00000169184,MGCR,MN1,Q10571"
MPL,"myeloproliferative leukaemia virus oncogene, thrombopoietin receptor",4352,1:43337849-43352772,1,1p34,Mis,"4352,ENSG00000117400,MPL,P40238"
MSH2,mutS homolog 2 (E. coli),4436,2:47403192-47482949,1,2p22-p21,"D, Mis, N, F, S","4436,COCA1,ENSG00000095002,MSH2,P43246"
MSH6,mutS homolog 6 (E. coli),2956,2:47783234-47806860,1,2p16,"Mis, N, F, S","2956,ENSG00000116062,GTBP,MSH6,P52701"
MSI2,musashi homolog 2 (Drosophila),124540,17:57257049-57631832,1,17q23.2,T,"124540,ENSG00000153944,MSI2,Q96DH6"
MSN,moesin,4478,X:65667842-65739893,1,Xq11.2-q12,T,"4478,ENSG00000147065,MSN,P26038"
MTCP1,mature T-cell proliferation 1,4515,X:155061843-155064023,1,Xq28,T,"100272147,CMC4,ENSG00000182712,MTCP1,MTCP1NB,P56277"
MTOR,mechanistic target of rapamycin,2475,1:11107485-11259409,1,1p36,"Mis, N","2475,ENSG00000198793,FRAP,FRAP1,FRAP2,MTOR,P42345"
MUC1,"mucin 1, transmembrane",4582,1:155186135-155192843,1,1q21,T,"4582,ENSG00000185499,MCKD1,MUC1,P15941,PUM"
MUTYH,mutY homolog (E. coli),4595,1:45329306-45340254,1,1p34.3-1p32.1,Mis,"4595,ENSG00000132781,MUTYH,Q9UIF7"
MYB,v-myb myeloblastosis viral oncogene homolog,4602,6:135181514-135217980,1,6q22-23,T,"4602,ENSG00000118513,MYB,P10242"
MYC,v-myc myelocytomatosis viral oncogene homolog (avian),4609,8:127738263-127740958,1,8q24.12-q24.13,"A, T","4609,ENSG00000136997,MYC,P01106"
MYCL,v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog,4610,1:39900814-39901434,1,1p34.2,A,"4610,ENSG00000116990,MYCL,MYCL1,P12524"
MYCN,"v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)",4613,2:15942065-15946097,1,2p24.1,"A, Mis","4613,ENSG00000134323,MYCN,NMYC,P04198"
MYD88,myeloid differentiation primary response gene (88),4615,3:38138662-38141286,1,3p22,Mis,"4615,ENSG00000172936,MYD88"
MYH11,"myosin, heavy polypeptide 11, smooth muscle",4629,16:15708811-15838252,1,16p13.13-p13.12,T,"4629,ENSG00000133392,MYH11"
MYH9,"myosin, heavy polypeptide 9, non-muscle",4627,22:36282668-36349236,1,22q13.1,T,"4627,DFNA17,ENSG00000100345,MYH9,P35579"
MYO5A,"myosin VA (heavy chain 12, myoxin)",4644,15:52313696-52528806,1,15q21,T,"4644,ENSG00000197535,MYH12,MYO5A,Q9Y4I1"
MYOD1,myogenic differentiation 1,4654,11:17719783-17721508,1,11p15.4,Mis,"4654,ENSG00000129152,MYF3,MYOD1,P15172"
NAB2,NGFI-A binding protein 2,4665,12:57089272-57094721,1,12q13.3,T,"4665,ENSG00000166886,NAB2,Q15742"
NBN,nibrin,4683,8:89935582-89984561,1,8q21,"Mis, N, F","4683,ENSG00000104320,NBN,NBS,NBS1,O60934"
NCOA1,nuclear receptor coactivator 1,8648,2:24658678-24768391,1,2p23,T,"8648,ENSG00000084676,NCOA1,Q15788"
NCOA2,nuclear receptor coactivator 2 (TIF2),10499,8:70113632-70216745,1,8q13.1,T,"10499,ENSG00000140396,NCOA2,Q15596"
NCOA4,nuclear receptor coactivator 4 - PTC3 (ELE1),8031,10:51579142-51586417,1,10q11.2,T,
NCOR1,nuclear receptor corepressor 1,9611,17:16032296-16194569,1,17p11.2,"Mis, F, N, O","9611,ENSG00000141027,NCOR1,O75376"
NCOR2,nuclear receptor corepressor 2,9612,12:124325402-124495251,1,12q24,"Mis, F, N, O","9612,ENSG00000196498,NCOR2,Q9Y618"
NDRG1,N-myc downstream regulated 1,10397,8:133238878-133284311,1,8q24.3,T,"10397,CAP43,ENSG00000104419,NDRG1,Q92597"
NF1,neurofibromatosis type 1 gene,4763,17:31095310-31374155,1,17q12,"D, Mis, N, F, S, O","4763,ENSG00000196712,NF1,P21359"
NF2,neurofibromatosis type 2 gene,4771,22:29603999-29694802,1,22q12.2,"D, Mis, N, F, S, O","4771,ENSG00000186575,NF2,P35240"
NFATC2,"nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2",4773,20:51391396-51542499,1,20q13.2,T,"4773,ENSG00000101096,NFATC2,Q13469"
NFE2L2,nuclear factor (erythroid-derived 2)-like 2 (NRF2),4780,2:177230785-177264576,1,2q31,Mis,"4780,ENSG00000116044,NFE2L2,Q16236"
NFIB,nuclear factor I/B,4781,9:14088309-14313511,1,9p24.1,T,"4781,ENSG00000147862,NFIB,O00712"
NFKB2,nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100),4791,10:102395960-102402376,1,10q24,T,
NFKBIE,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon",4794,6:44259219-44265763,1,6p21.1,"F, Mis","4794,ENSG00000146232,NFKBIE,O00221"
NIN,ninein (GSK3B interacting protein),51199,14:50725872-50822056,1,14q24,T,"51199,ENSG00000100503,NIN,Q8N4C6"
NKX2-1,NK2 homeobox 1,7080,14:36517278-36519357,1,14q13,A,"7080,BCH,ENSG00000136352,NKX2-1,NKX2A,P43699,TITF1"
NONO,"non-POU domain containing, octamer-binding",4841,X:71290638-71300076,1,Xq13.1,T,"4841,ENSG00000147140,NONO,Q15233"
NOTCH1,"Notch homolog 1, translocation-associated (Drosophila) (TAN1)",4851,9:136496071-136545786,1,9q34.3,"T, Mis, O","4851,ENSG00000148400,NOTCH1,P46531,TAN1"
NOTCH2,Notch homolog 2,4853,1:119915306-120069406,1,1p13-p11,"N, F, Mis","4853,ENSG00000134250,NOTCH2,Q04721"
NPM1,"nucleophosmin (nucleolar phosphoprotein B23, numatrin)",4869,5:171387949-171410565,1,5q35,"T, F","4869,ENSG00000181163,NPM1,P06748"
NR4A3,"nuclear receptor subfamily 4, group A, member 3 (NOR1)",8013,9:99828041-99863867,1,9q22,T,"8013,ENSG00000119508,NR4A3,Q92570"
NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,4893,1:114708535-114716160,1,1p13.2,Mis,"4893,ENSG00000213281,NRAS,P01111"
NRG1,neuregulin 1,3084,8:32548727-32764402,1,8p12,T,"3084,ENSG00000157168,HGL,NRG1,NRG1-IT2,Q02297"
NSD1,nuclear receptor binding SET domain protein 1,64324,5:177135104-177295459,1,5q35,T,"64324,ENSG00000165671,NSD1,Q96L73,STO"
NT5C2,"5'-nucleotidase, cytosolic II",22978,10:103089672-103174958,1,10q24.32,Mis,"22978,ENSG00000076685,NT5B,NT5C2,P49902"
NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",4914,1:156860935-156881642,1,1q21-q22,"T, A","4914,ENSG00000198400,NTRK1,P04629"
NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",4916,15:87876935-88256153,1,15q25,T,"4916,ENSG00000140538,NTRK3,Q16288"
NUMA1,nuclear mitotic apparatus protein 1,4926,11:72003527-72035943,1,11q13,T,"4926,ENSG00000137497,NUMA1,Q14980"
NUP214,nucleoporin 214kDa (CAN),8021,9:131125705-131233487,1,9q34.1,T,"8021,ENSG00000126883,NUP214,P35658"
NUP98,nucleoporin 98kDa,4928,11:3676159-3782117,1,11p15,T,"4928,ENSG00000110713,NUP98,P52948"
NUTM1,"NUT midline carcinoma, family member 1",256646,15:34346021-34357492,1,15q14,T,"256646,C15orf55,ENSG00000184507,NUTM1,Q86Y26"
NUTM2A,NUT family member 2A,728118,10:87358266-87367372,1,10q23.2,T,"ENSG00000214562,FAM22D,NUTM2D,Q5VT03"
NUTM2B,NUT family member 2B,729262,10:79703610-79712485,1,10q22.3,T,"729262,A6NNL0,ENSG00000188199,FAM22B,NUTM2B"
OLIG2,oligodendrocyte lineage transcription factor 2 (BHLHB1),10215,21:33026863-33027834,1,21q22.11,T,"10215,BHLHB1,ENSG00000205927,OLIG2,PRKCBP2,Q13516"
P2RY8,"purinergic receptor P2Y, G-protein coupled, 8",286530,"X,Y:1465479-1466558",1,"Xp22.3; Yp11.3",T,"286530,ENSG00000182162,P2RY8,Q86VZ1"
PAFAH1B2,"platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa",5049,11:117152449-117167700,1,11q23,T,"5049,ENSG00000168092,P68402,PAFAH1B2"
PALB2,partner and localizer of BRCA2,79728,16:23603459-23641157,1,16p12.1,"F, N, Mis","79728,ENSG00000083093,PALB2,Q86YC2"
PAX3,paired box gene 3,5077,2:222201174-222298615,1,2q35,T,"5077,ENSG00000135903,P23760,PAX3,WS1"
PAX5,paired box gene 5 (B-cell lineage specific activator protein),5079,9:36840560-37034031,1,9p13,"T, Mis, D, F, S","5079,ENSG00000196092,PAX5,Q02548"
PAX7,paired box gene 7,5081,1:18631604-18736039,1,1p36.2-p36.12,T,"5081,ENSG00000009709,P23759,PAX7"
PAX8,paired box gene 8,7849,2:113218533-113278394,1,2q12-q14,T,"7849,ENSG00000125618,PAX8,Q06710"
PBRM1,polybromo 1,55193,3:52548063-52679711,1,3p21,"Mis, N, F, S, D, O","55193,ENSG00000163939,PBRM1,Q86U86"
PBX1,pre-B-cell leukemia transcription factor 1,5087,1:164559824-164846677,1,1q23,T,"5087,ENSG00000185630,P40424,PBX1"
PCM1,pericentriolar material 1  (PTC4),5108,8:17935611-18027662,1,8p22-p21.3,T,"5108,ENSG00000078674,PCM1,Q15154"
PDCD1LG2,programmed cell death 1 ligand 2,80380,9:5522547-5569959,1,9p24.2,T,"80380,ENSG00000197646,PDCD1LG2,Q9BQ51"
PDE4DIP,phosphodiesterase 4D interacting protein (myomegalin),9659,1:148889754-149031985,1,1q12,T,"9659,CMYA2,ENSG00000178104,PDE4DIP,Q5VU43"
PDGFB,platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog),5155,22:39225723-39243963,1,22q12.3-q13.1,T,"5155,ENSG00000100311,P01127,PDGFB,SIS"
PDGFRA,"platelet-derived growth factor, alpha-receptor",5156,4:54258769-54295272,1,4q11-q13,"Mis, O, T","5156,ENSG00000134853,P16234,PDGFRA"
PDGFRB,"platelet-derived growth factor receptor, beta polypeptide",5159,5:150115763-150137047,1,5q31-q32,T,"5159,ENSG00000113721,P09619,PDGFR,PDGFRB"
PER1,period homolog 1 (Drosophila),5187,17:8141068-8150706,1,17p13.1-17p12,T,"5187,ENSG00000179094,O15534,PER,PER1"
PHF6,PHD finger protein 6,84295,X:134377618-134425330,1,Xq26.3,"F, N, S, Mis","84295,BFLS,BORJ,ENSG00000156531,PHF6,Q8IWS0"
PHOX2B,paired-like homeobox 2b,8929,4:41745807-41748610,1,4p12,"Mis, F","8929,ENSG00000109132,PHOX2B,PMX2B,Q99453"
PICALM,phosphatidylinositol binding clathrin assembly protein (CALM),8301,11:85959046-86068780,1,11q14,T,"8301,ENSG00000073921,PICALM,Q13492"
PIK3CA,"phosphoinositide-3-kinase, catalytic, alpha polypeptide",5290,3:179198826-179234364,1,3q26.3,Mis,"5290,ENSG00000121879,P42336,PIK3CA"
PIK3CB,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",5291,3:138655389-138759343,1,3q22.3,Mis,"5291,ENSG00000051382,P42338,PIK3C1,PIK3CB"
PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",5295,5:68226676-68297601,1,5q13.1,"Mis, F, O","5295,ENSG00000145675,P27986,PIK3R1"
PIM1,pim-1 oncogene,5292,6:37170576-37174091,1,6p21.2,T,"5292,ENSG00000137193,P11309,PIM,PIM1"
PLAG1,pleiomorphic adenoma gene 1,5324,8:56166243-56168269,1,8q12,T,"5324,ENSG00000181690,PLAG1,Q6DJT9"
PLCG1,"phospholipase C, gamma 1",5335,20:41137642-41174509,1,20q12-q13.1,Mis,"5335,ENSG00000124181,P19174,PLC1,PLCG1"
PML,promyelocytic leukemia,5371,15:73994813-74045008,1,15q22,T,"5371,ENSG00000140464,P29590,PML"
PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),5395,7:5973399-6009019,1,7p22,"Mis, N, F","5395,ENSG00000122512,P54278,PMS2,PMSL2"
POLD1,"DNA polymerase delta 1, catalytic subunit",5424,19:50398852-50417947,1,19q13.3,Mis,"5424,ENSG00000062822,P28340,POLD,POLD1"
POLE,"polymerase (DNA directed), epsilon, catalytic subunit",5426,12:132624697-132687315,1,12q24.3,Mis,"5426,ENSG00000177084,POLE,Q07864"
POLQ,DNA polymerase theta,10721,3:121432304-121546641,1,3q13.33,Mis,"10721,ENSG00000051341,POLQ"
POT1,protection of telomeres 1,25913,7:124823962-124897173,1,7q31.33,"Mis, N","25913,ENSG00000128513,POT1,Q9NUX5"
POU2AF1,"POU domain, class 2, associating factor 1 (OBF1)",5450,11:111354261-111379177,1,11q23.1,T,"5450,ENSG00000110777,POU2AF1,Q16633"
POU5F1,"POU domain, class 5, transcription factor 1",5460,6:31164601-31170620,1,6p21.31,T,"5460,ENSG00000204531,OTF3,POU5F1,Q01860"
PPARG,"peroxisome proliferative activated receptor, gamma",5468,3:12351593-12434145,1,3p25,T,"5468,ENSG00000132170,P37231,PPARG"
PPFIBP1,"PTPRF interacting protein, binding protein 1 (liprin beta 1)",8496,12:27633397-27692882,1,12p12.1,T,"8496,ENSG00000110841,PPFIBP1,Q86W92"
PPM1D,"protein phosphatase, Mg2+/Mn2+ dependent 1D",8493,17:60600415-60663552,1,17q23.3,"A, Mis, N, F","8493,ENSG00000170836,O15297,PPM1D"
PPP2R1A,"protein phosphatase 2, regulatory subunit A, alpha",5518,19:52190097-52225981,1,19q13.41,Mis,"5518,ENSG00000105568,P30153,PPP2R1A"
PPP6C,"protein phosphatase 6, catalytic subunit",5537,9:125149673-125189718,1,9q33.3,"Mis, N","5537,ENSG00000119414,O00743,PPP6C"
PRCC,papillary renal cell carcinoma (translocation-associated),5546,1:156767772-156800460,1,1q21.1,T,"5546,ENSG00000143294,PRCC,Q92733"
PRDM1,"PR domain containing 1, with ZNF domain",639,6:106088267-106107486,1,6q21,"D, N, Mis, F, S","639,BLIMP1,ENSG00000057657,O75626,PRDM1"
PRDM16,PR domain containing 16,63976,1:3069260-3433811,1,1p36.23-p33,T,"63976,ENSG00000142611,PRDM16,Q9HAZ2"
PREX2,"phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2",80243,8:67952395-68231378,1,8q13.2,"Mis, N","80243,DEPDC2,ENSG00000046889,PREX2,Q70Z35"
PRF1,perforin 1 (pore forming protein),5551,10:70598053-70600902,1,10q22,M,"5551,ENSG00000180644,P14222,PRF1"
PRKACA,protein kinase cAMP-activated catalytic subunit alpha,5566,19:14093112-14117547,1,19p13.1,"T, Mis, N","5566,ENSG00000072062,P17612,PRKACA"
PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)",5573,17:68515400-68530449,1,17q23-q24,"T, Mis, N, F, S","5573,ENSG00000108946,P10644,PRKAR1,PRKAR1A,TSE1"
PRRX1,paired related homeobox 1,5396,1:170664220-170730332,1,1q24,T,"5396,ENSG00000116132,P54821,PMX1,PRRX1"
PSIP1,PC4 and SFRS1 interacting protein 1 (LEDGF),11168,9:15471207-15510188,1,9p22.3,T,"11168,ENSG00000164985,O75475,PSIP1,PSIP2"
PTCH1,Homolog of Drosophila Patched gene,5727,9:95446912-95508361,1,9q22.3,"Mis, N, F, S","5727,ENSG00000185920,NBCCS,PTCH,PTCH1,Q13635"
PTEN,phosphatase and tensin homolog gene,5728,10:87864470-87965472,1,10q23.3,"D, Mis, N, F, S","5728,BZS,ENSG00000171862,MHAM,P60484,PTEN"
PTK6,protein tyrosine kinase 6,5753,20:63529536-63537314,1,20q13.3,"Mis, N","5753,ENSG00000101213,PTK6,Q13882"
PTPN11,"protein tyrosine phosphatase, non-receptor type 11",5781,12:112419112-112504764,1,12q24.1,Mis,"5781,ENSG00000179295,NS1,PTPN11,Q06124"
PTPN13,"protein tyrosine phosphatase, non-receptor type 13",5783,4:86635257-86814551,1,4q21.3,"Mis, N","5783,ENSG00000163629,PTPN13,Q12923"
PTPRB,"protein tyrosine phosphatase, receptor type, B",5787,12:70521489-70609814,1,12q15-q21,"N, Mis, S, F","5787,ENSG00000127329,P23467,PTPB,PTPRB"
PTPRC,"protein tyrosine phosphatase, receptor type, C",5788,1:198639275-198756181,1,1q31-q32,"Mis, N, S","5788,CD45,ENSG00000081237,PTPRC"
PTPRK,"protein tyrosine phosphatase, receptor type, K",5796,6:127970227-128520358,1,6q22.2-q22.3,T,"5796,ENSG00000152894,PTPRK,Q15262"
PTPRT,"protein tyrosine phosphatase, receptor type T",11122,20:42080879-43189733,1,20q12-q13,"Mis, N","11122,ENSG00000196090,O14522,PTPRT"
QKI,"QKI, KH domain containing, RNA binding",9444,6:163415194-163570710,1,6q26,"Mis, F, T","9444,ENSG00000112531,Q96PU8,QKI"
RABEP1,"rabaptin, RAB GTPase binding effector protein 1",9135,17:5282488-5383224,1,17p13.2,T,"9135,ENSG00000029725,Q15276,RABEP1"
RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",5879,7:6374736-6402446,1,7p22,"Mis, F","5879,ENSG00000136238,P63000,RAC1"
RAD21,RAD21 homolog (S. pombe),5885,8:116847500-116866729,1,8q24.11,"Mis, N, F","5885,ENSG00000164754,O60216,RAD21"
RAD51B,RAD51 paralog B,5890,14:67823544-68594603,1,14q23-q24.2,T,"5890,ENSG00000182185,O15315,RAD51B,RAD51L1"
RAF1,v-raf-1 murine leukemia viral oncogene homolog 1,5894,3:12584514-12618721,1,3p25,"T, A","5894,ENSG00000132155,P04049,RAF1"
RANBP2,RAN binding protein 2,5903,2:108719607-108783901,1,2q12.3,T,"5903,ANE1,ENSG00000153201,P49792,RANBP2"
RAP1GDS1,"RAP1, GTP-GDP dissociation stimulator 1",5910,4:98261566-98442117,1,4q21-q25,T,"5910,ENSG00000138698,P52306,RAP1GDS1"
RARA,"retinoic acid receptor, alpha",5914,17:40331219-40356226,1,17q12,T,"5914,ENSG00000131759,P10276,RARA"
RB1,retinoblastoma gene,5925,13:48303913-48480071,1,13q14,"D, Mis, N, F, S","5925,ENSG00000139687,OSRC,P06400,RB1"
RBM10,RNA binding motif protein 10,8241,X:47147482-47186599,1,Xp11.3,"Mis, F, N","8241,ENSG00000182872,P98175,RBM10"
RBM15,RNA binding motif protein 15,64783,1:110339407-110345610,1,1p13,T,"64783,ENSG00000162775,Q96T37,RBM15"
RECQL4,RecQ protein-like 4,9401,8:144511431-144517784,1,8q24.3,"N, F, S","9401,ENSG00000160957,RECQ4,RECQL4,RTS,RecQ4"
REL,v-rel reticuloendotheliosis viral oncogene homolog (avian),5966,2:60881841-60922535,1,2p13-p12,A,"5966,ENSG00000162924,Q04864,REL"
RET,ret proto-oncogene,5979,10:43077259-43128269,1,10q11.2,"T, Mis, N, F","5979,ENSG00000165731,HSCR1,MEN2A,MEN2B,MTC1,P07949,RET"
RHOA,ras homolog family member A,387,3:49360209-49375589,1,3p21.3,"Mis, F, O","387,ARH12,ARHA,ENSG00000067560,P61586,RHOA"
RHOH,ras homolog family member H,399,4:40243387-40243962,1,4p13,T,"399,ARHH,ENSG00000168421,Q15669,RHOH"
RMI2,RecQ mediated genome instability 2,116028,16:11345472-11350790,1,16p13.13,T,"116028,C16orf75,ENSG00000175643,Q96E14,RMI2"
RNF213,ring finger protein 213,57674,17:80340149-80393498,1,17q25.3,T,"57674,C17orf27,ENSG00000173821,KIAA1618,MYMY2,RNF213"
RNF43,ring finger protein 43,54894,17:58354943-58415577,1,17q23.2,"Mis, N, F, S","54894,ENSG00000108375,Q68DV7,RNF43"
ROS1,v-ros UR2 sarcoma virus oncogene homolog 1 (avian),6098,6:117288492-117425656,1,6q22,T,"6098,ENSG00000047936,P08922,ROS1"
RPL10,ribosomal protein L10,6134,X:154398520-154400854,1,Xq28,Mis,"6134,ENSG00000147403,P27635,RPL10"
RPL22,ribosomal protein L22 (EAP),6146,1:6186672-6199573,1,1p36.31,T,"6146,ENSG00000116251,P35268,RPL22"
RPL5,ribososomal protein L5,6125,1:92832115-92841865,1,1p22.1,"Mis, N, F","6083,ENSG00000122406,P46777,RPL5"
RPN1,ribophorin I,6184,3:128620411-128650800,1,3q21.3-q25.2,T,"6184,ENSG00000163902,P04843,RPN1"
RSPO2,R-spondin 2,340419,8:107901075-108082638,1,8q23.1,T,"340419,ENSG00000147655,Q6UXX9,RSPO2"
RSPO3,R-spondin 3,84870,6:127119193-127196007,1,6q22.33,T,"84870,ENSG00000146374,Q9BXY4,RSPO3,THSD2"
RUNX1,runt-related transcription factor 1  (AML1),861,21:34792135-35048899,1,21q22.3,T,"861,AML1,CBFA2,ENSG00000159216,Q01196,RUNX1"
RUNX1T1,"runt-related transcription factor 1; translocated to, 1 (cyclin D-related)",862,8:91960242-92017340,1,8q22,T,"862,AML1T1,CBFA2T1,ENSG00000079102,Q06455,RUNX1T1"
SALL4,spalt like transcription factor 4,57167,20:51784265-51802408,1,20q13.2,"Mis, F","57167,ENSG00000101115,Q9UJQ4,SALL4"
SBDS,Shwachman-Bodian-Diamond syndrome protein,51119,7:66988371-66995417,1,7q11,"F, N, O","51119,ENSG00000126524,Q9Y3A5,SBDS"
SDC4,syndecan 4,6385,20:45327264-45348384,1,20q12,T,"6385,ENSG00000124145,P31431,SDC4"
SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",6389,5:218356-256420,1,5p15,"Mis, N","6389,ENSG00000073578,P31040,SDH2,SDHA"
SDHAF2,succinate dehydrogenase complex assembly factor 2,54949,11:61430147-61446071,1,11q12.2,M,"54949,C11orf79,ENSG00000167985,PGL2,Q9NX18,SDHAF2"
SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",6390,1:17018881-17054019,1,1p36.1-p35,"Mis, N, F","6390,ENSG00000117118,P21912,SDH,SDH1,SDHB"
SDHC,"succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa",6391,1:161314406-161362433,1,1q21,"Mis, N, F","55973,6391,BCAP29,ENSG00000075790,ENSG00000143252,PGL3,Q99643,Q9UHQ4,SDHC"
SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",6392,11:112086908-112094970,1,11q23,"Mis, N, F, S","6392,ENSG00000204370,O14521,PGL,PGL1,SDHD"
SET,SET translocation,6418,9:128689583-128694664,1,9q34,T,"6418,ENSG00000119335,Q01105,SET"
SETBP1,SET binding protein 1,26040,18:44701347-45063698,1,18q21.1,"Mis, T","26040,ENSG00000152217,Q9Y6X0,SETBP1"
SETD2,SET domain containing 2,29072,3:47017093-47123126,1,3p21.31,"N, F, S, Mis","29072,ENSG00000181555,SETD2"
SF3B1,"splicing factor 3b, subunit 1, 155kDa",23451,2:197392303-197434999,1,2q33.1,Mis,"23451,ENSG00000115524,O75533,SF3B1"
SFPQ,splicing factor proline/glutamine rich(polypyrimidine tract binding protein associated),6421,1:35184456-35193049,1,1p34.3,T,"6421,ENSG00000116560,P23246,SFPQ"
SFRP4,secreted frizzled related protein 4,6424,7:37907479-37916537,1,7p14.1,Mis,"6424,ENSG00000106483,Q6FHJ7,SFRP4"
SH2B3,SH2B adaptor protein 3,10019,12:111418146-111448302,1,12q24.12,"Mis, F, N","10019,ENSG00000111252,Q9UQQ2,SH2B3"
SH3GL1,SH3-domain GRB2-like 1 (EEN),6455,19:4361600-4400368,1,19p13.3,T,"6455,ENSG00000141985,Q99961,SH3GL1"
SIX1,SIX homeobox 1,6495,14:60646283-60649189,1,14q23.1,Mis,"6495,DFNA23,ENSG00000126778,Q15475,SIX1"
SLC34A2,"solute carrier family 34 (sodium phosphate), member 2",10568,4:25662501-25676749,1,4p15.2,T,"10568,ENSG00000157765,O95436,SLC34A2"
SLC45A3,"solute carrier family 45, member 3",85414,1:205659234-205664656,1,1q32,T,"85414,ENSG00000158715,PCANAP2,PCANAP6,PCANAP8,Q96JT2,SLC45A3"
SMAD2,SMAD family member 2,4087,18:47841827-47896756,1,18q21,"Mis, N","4087,ENSG00000175387,MADH2,Q15796,SMAD2"
SMAD3,SMAD family member 3,4088,15:67066155-67190536,1,15q21-q22,Mis,"4088,ENSG00000166949,MADH3,P84022,SMAD3"
SMAD4,SMAD family member 4,4089,18:51047047-51078467,1,18q21.1,"D, Mis, N, F","4089,ENSG00000141646,MADH4,Q13485,SMAD4"
SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",6597,19:10984152-11061816,1,19p13.2,"F, N, Mis, S","6597,ENSG00000127616,P51532,SMARCA4,SNF2L4"
SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",6598,22:23787170-23834180,1,22q11,"D, N, F, S","6598,ENSG00000099956,Q12824,SMARCB1,SNF5L1"
SMARCD1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1",6602,12:50085487-50099000,1,12q13-q14,N,"6602,ENSG00000066117,Q96GM5,SMARCD1"
SMARCE1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1",6605,17:40628785-40645626,1,17q21.2,"F, Mis, N","6605,ENSG00000073584,Q969G3,SMARCE1"
SMO,smoothened homolog (Drosophila),6608,7:129189152-129212451,1,7q31-q32,Mis,"6608,ENSG00000128602,Q99835,SMO,SMOH"
SND1,staphylococcal nuclease and tudor domain containing 1,27044,7:127652374-128092058,1,7q31.3,T,"27044,ENSG00000197157,Q7KZF4,SND1"
SOCS1,suppressor of cytokine signaling 1,8651,16:11254843-11255478,1,16p13.13,"F, O","8651,ENSG00000185338,O15524,SOCS1"
SOX2,SRY (sex determining region Y)-box 2,6657,3:181712361-181713314,1,3q26.3-q27,A,"6657,ENSG00000181449,P48431,SOX2"
SPEN,spen family transcriptional repressor,23013,1:15848068-15939427,1,1p36,"F, Mis, N","23013,ENSG00000065526,Q96T58,SPEN"
SPOP,speckle type POZ protein,8405,17:49600378-49622810,1,17q21.33,Mis,"8405,ENSG00000121067,O43791,SPOP"
SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",6714,20:37384154-37403379,1,20q11.23,"Mis, N","6714,ENSG00000197122,P12931,SRC,SRC1"
SRSF2,serine/arginine-rich splicing factor 2,6427,17:76736161-76737160,1,17q25,Mis,"6427,ENSG00000161547,Q01130,SFRS2,SRSF2"
SRSF3,serine/arginine-rich splicing factor 3,6428,6:36596763-36601989,1,6p21,T,"6428,ENSG00000112081,P84103,SFRS3,SRSF3"
SS18,"synovial sarcoma translocation, chromosome 18",6760,18:26018354-26090569,1,18q11.2,T,"6760,ENSG00000141380,Q15532,SS18,SSXT"
SS18L1,synovial sarcoma translocation gene on chromosome 18-like 1,26039,20:62143822-62179209,1,20q13.3,T,"26039,ENSG00000184402,O75177,SS18L1"
SSX1,"synovial sarcoma, X breakpoint 1",6756,X:48257242-48266387,1,Xp11.23-p11.22,T,"6756,ENSG00000126752,Q16384,SSX1"
SSX2,"synovial sarcoma, X breakpoint 2",6757,X:52752681-52789480,1,Xp11.23-p11.22,T,"6757,ENSG00000241476,Q16385,SSX,SSX2"
SSX4,"synovial sarcoma, X breakpoint 4",6759,X:48391869-48411372,1,Xp11.23,T,"6759,ENSG00000204645,O60224,SSX4"
STAG2,stromal antigen 2,10735,X:124022628-124100597,1,Xq25,"Mis, N, F, S","10735,ENSG00000101972,Q8N3U4,STAG2"
STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),6774,17:42315745-42348516,1,17q21.31,"Mis,O","6774,ENSG00000168610,P40763,STAT3"
STAT5B,signal transducer and activator of transcription 5B,6777,17:42201738-42232127,1,17q11.2,"Mis, O, T","6777,ENSG00000173757,P51692,STAT5B"
STAT6,"signal transducer and activator of transcription 6, interleukin-4 induced",6778,12:57096572-57108278,1,12q13,T,"6778,ENSG00000166888,P42226,STAT6"
STIL,SCL/TAL1 interrupting locus,6491,1:47251136-47310319,1,1p32,T,"6491,ENSG00000123473,Q15468,SIL,STIL"
STK11,serine/threonine kinase 11 gene (LKB1),6794,19:1206914-1226647,1,19p13.3,"D, Mis, N, F, S","6794,ENSG00000118046,Q15831,STK11"
STRN,"striatin, calmodulin binding protein",6801,2:36849456-36966463,1,2p22.2,T,"6801,ENSG00000115808,O43815,STRN"
SUFU,suppressor of fused homolog (Drosophila),51684,10:102504153-102630155,1,10q24.32,"D, F, S","51684,ENSG00000107882,Q9UMX1,SUFU"
SUZ12,suppressor of zeste 12 homolog (Drosophila),23512,17:31937247-31999003,1,17q11.2,T,"23512,ENSG00000178691,Q15022,SUZ12"
SYK,spleen tyrosine kinase,6850,9:90843899-90895600,1,9q22,T,"6850,ENSG00000165025,P43405,SYK"
TAF15,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa",8148,17:35809571-35846946,1,17q11.1-q11.2,T,"8148,ENSG00000172660,Q92804,TAF15,TAF2N"
TAL1,T-cell acute lymphocytic leukemia 1 (SCL),6886,1:47219720-47225888,1,1p32,T,"6886,ENSG00000162367,P17542,TAL1,TCL5"
TAL2,T-cell acute lymphocytic leukemia 2,6887,9:108424779-108425393,1,9q31,T,
TBL1XR1,transducin (beta)-like 1 X-linked receptor 1,79718,3:177025498-177064977,1,3q26.32,"F, Mis","79718,ENSG00000177565,Q9BZK7,TBL1XR1"
TBX3,T-box 3,6926,12:114671841-114683200,1,12q24.21,"Mis, N, F, O","6926,ENSG00000135111,O15119,TBX3,UMS"
TCEA1,"transcription elongation factor A (SII), 1",6917,8:53970288-53984488,1,8q11.2,T,"6917,ENSG00000187735,TCEA1"
TCF12,"transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)",6938,15:56919914-57288514,1,15q21,T,"6938,ENSG00000140262,Q99081,TCF12"
TCF3,transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47),6929,19:1611707-1650248,1,19p13.3,T,"6929,ENSG00000071564,P15923,TCF3"
TCF7L2,transcription factor 7-like 2,6934,10:112950757-113165972,1,10q25.3,T,"6934,ENSG00000148737,Q9NQB0,TCF4,TCF7L2"
TCL1A,T-cell leukemia/lymphoma 1A,8115,14:95711755-95714066,1,14q32.1,T,"8115,ENSG00000100721,P56279,TCL1A"
TERT,telomerase reverse transcriptase,7015,5:1253728-1294989,1,5p15.33,Promoter Mis,"7015,ENSG00000164362,O14746,TERT"
TET1,tet methylcytosine dioxygenase 1,80312,10:68572340-68691815,1,10q21,T,"80312,CXXC6,ENSG00000138336,Q8NFU7,TET1"
TET2,tet oncogene family member 2,54790,4:105233943-105276519,1,4q24,"Mis, N, F","54790,ENSG00000168769,KIAA1546,Q6N021,TET2"
TFE3,transcription factor binding to IGHM enhancer 3,7030,X:49030158-49043226,1,Xp11.22,T,"7030,ENSG00000068323,P19532,TFE3"
TFEB,transcription factor EB,7942,6:41684599-41691213,1,6p21,T,"7942,ENSG00000112561,P19484,TFEB"
TFG,TRK-fused gene,10342,3:100713687-100748532,1,3q11-q12,T,"10342,ENSG00000114354,Q92734,TFG"
TGFBR2,transforming growth factor beta receptor II,7048,3:30606884-30691599,1,3p22,"Mis, F, N","7048,ENSG00000163513,MFS2,P37173,TGFBR2"
TLX1,"T-cell leukemia, homeobox 1 (HOX11)",3195,10:101131543-101136914,1,10q24,T,"3195,ENSG00000107807,HOX11,P31314,TCL3,TLX1"
TLX3,"T-cell leukemia, homeobox 3 (HOX11L2)",30012,5:171309367-171311600,1,5q35.1,T,"30012,ENSG00000164438,HOX11L2,O43711,TLX3"
TMEM127,transmembrane protein 127,55654,2:96253808-96265381,1,2q11.2,"F, N","55654,ENSG00000135956,O75204,TMEM127"
TMPRSS2,"transmembrane protease, serine 2",7113,21:41466142-41498133,1,21q22.3,T,"7113,ENSG00000184012,O15393,TMPRSS2"
TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",7128,6:137871228-137881319,1,6q23,"D, N, F","7128,ENSG00000118503,P21580,TNFAIP3"
TNFRSF14,"tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)",8764,1:2556665-2563273,1,1p36.32,"Mis, N, F","8764,ENSG00000157873,Q92956,TNFRSF14"
TNFRSF17,"tumor necrosis factor receptor superfamily, member 17",608,16:11965325-11967847,1,16p13.1,T,"608,BCMA,ENSG00000048462,Q02223,TNFRSF17"
TOP1,topoisomerase (DNA) I,7150,20:41029068-41123297,1,20q12-q13.1,T,"7150,ENSG00000198900,P11387,TOP1"
TP53,tumor protein p53,7157,17:7669609-7676594,1,17p13,"Mis, N, F, T","7157,ENSG00000141510,P04637,TP53"
TP63,tumor protein p63,8626,3:189631516-189894502,1,3q28,"Mis, N, T","8626,ENSG00000073282,Q9H3D4,TP53CP,TP53L,TP63,TP73L"
TPM3,tropomyosin 3,7170,1:154157639-154183119,1,1q22-q23,T,"7170,ENSG00000143549,NEM1,P06753,TPM3"
TPM4,tropomyosin 4,7171,19:16076567-16101347,1,19p13.1,T,"7171,ENSG00000167460,P67936,TPM4"
TPR,translocated promoter region,7175,1:186313971-186375028,1,1q25,T,"7175,ENSG00000047410,P12270,TPR"
TRA,T cell receptor alpha locus,6955,14:-,1,14q11.2,T,
TRAF7,tumour necrosis factor receptor-associated factor 7,84231,16:2163921-2176574,1,16p13.3,Mis,"84231,ENSG00000131653,Q6Q0C0,RFWD1,TRAF7"
TRB,T cell receptor beta locus,6957,7:-,1,7q34,T,
TRD,T cell receptor delta locus,6964,14:-,1,14q11.2,T,
TRIM24,tripartite motif containing 24,8805,7:138460549-138584951,1,7q32-q34,T,"8805,ENSG00000122779,O15164,TIF1,TRIM24"
TRIM27,tripartite motif-containing 27,5987,6:28904070-28923632,1,6p22,T,"5987,ENSG00000204713,P14373,RFP,TRIM27"
TRIM33,"tripartite motif-containing 33 (PTC7,TIF1G)",51592,1:114397648-114511076,1,1p13,T,"51592,ENSG00000197323,Q9UPN9,TRIM33"
TRIP11,thyroid hormone receptor interactor 11,9321,14:91969673-92039685,1,14q31-q32,T,"9321,ENSG00000100815,Q15643,TRIP11"
TRRAP,transformation/transcription domain-associated protein,8295,7:98881151-99012355,1,7q21.2-q22.1,Mis,"8295,ENSG00000196367,Q9Y4A5,TRRAP"
TSC1,tuberous sclerosis 1 gene,7248,9:132896235-132928872,1,9q34,"D, Mis, N, F, S","7248,ENSG00000165699,Q92574,TSC,TSC1"
TSC2,tuberous sclerosis 2 gene,7249,16:2048616-2088610,1,16p13.3,"D, Mis, N, F, S","7249,ENSG00000103197,P49815,TSC2,TSC4"
TSHR,thyroid stimulating hormone receptor,7253,14:80955681-81144353,1,14q31,Mis,"7253,ENSG00000165409,TSHR"
U2AF1,U2 small nuclear RNA auxiliary factor 1,7307,21:43093102-43107494,1,21q22.3,Mis,"7307,ENSG00000160201,Q01081,U2AF1,U2AFBP"
UBR5,ubiquitin protein ligase E3 component n-recognin 5,51366,8:102254302-102412234,1,8q22,"F, N, Mis, S","51366,EDD1,ENSG00000104517,O95071,UBR5"
USP6,ubiquitin specific peptidase 6 (Tre-2 oncogene),9098,17:5130368-5148597,1,17p13,T,"9098,ENSG00000129204,HRP1,P35125,TRESMCR,USP6"
USP8,ubiquitin specific peptidase 8,9101,15:50439074-50499088,1,15q21.1,"Mis, N","9101,ENSG00000138592,P40818,USP8"
VHL,von Hippel-Lindau syndrome gene,7428,3:10141848-10149965,1,3p25,"D, Mis, N, F, S","7428,ENSG00000134086,P40337,VHL"
WAS,Wiskott-Aldrich syndrome,7454,X:48683854-48691162,1,Xp11.23-p11.22,"Mis, N, F, S","7454,ENSG00000015285,IMD2,P42768,THC,WAS"
WHSC1,Wolf-Hirschhorn syndrome candidate 1(MMSET),7468,4:1900655-1978909,1,4p16.3,T,"7468,ENSG00000109685,O96028,WHSC1"
WHSC1L1,Wolf-Hirschhorn syndrome candidate 1-like 1 (NSD3),54904,8:38317956-38348171,1,8p12,"T, A","54904,ENSG00000147548,Q9BZ95,WHSC1L1"
WIF1,WNT inhibitory factor 1,11197,12:65051349-65121191,1,12q14.3,T,"11197,ENSG00000156076,Q9Y5W5,WIF1"
WRN,Werner syndrome (RECQL2),7486,8:31058448-31173102,1,8p12-p11.2,"Mis, N, F, S","7486,ENSG00000165392,Q14191,WRN"
WT1,Wilms tumour 1 gene,7490,11:32389058-32435141,1,11p13,"D, Mis, N, F, S, T","7490,ENSG00000184937,GUD,WT1"
WWTR1,WW domain containing transcription regulator 1,25937,3:149520805-149657306,1,3q23-q24,T,"25937,ENSG00000018408,Q9GZV5,WWTR1"
XPA,"xeroderma pigmentosum, complementation group A",7507,9:97675439-97697292,1,9q22.3,"Mis, N, F, S","7507,ENSG00000136936,P23025,XPA"
XPC,"xeroderma pigmentosum, complementation group C",7508,3:14145941-14178568,1,3p25,"Mis, N, F, S","7508,ENSG00000154767,Q01831,XPC"
XPO1,"exportin 1 (CRM1 homolog, yeast)",7514,2:61478820-61533897,1,2p15,Mis,"7514,ENSG00000082898,O14980,XPO1"
YWHAE,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (14-3-3 epsilon)",7531,17:1345447-1400110,1,17p13.3,T,"7531,ENSG00000108953,P62258,YWHAE"
ZBTB16,zinc finger and BTB domain containing 16,7704,11:114063302-114250556,1,11q23.1,T,"7704,ENSG00000109906,Q05516,ZBTB16,ZNF145"
ZFHX3,zinc finger homeobox 3,463,16:72787164-72960145,1,16q22.3,"Mis, N","463,ATBF1,ENSG00000140836,Q15911,ZFHX3"
ZNF198,zinc finger protein 198,7750,13:19993073-20086014,1,13q11-q12,T,"7750,ENSG00000121741,Q9UBW7,ZMYM2,ZNF198"
ZNF278,zinc finger protein 278 (ZSG),23598,22:31326891-31345602,1,22q12-q14,T,"23598,ENSG00000100105,PATZ1,Q9HBE1,ZNF278"
ZNF331,zinc finger protein 331,55422,19:53569378-53577953,1,19q13.3-q13.4,T,"55422,ENSG00000130844,Q9NQX6,ZNF331"
ZNF384,zinc finger protein 384 (CIZ/NMP4),171017,12:6667714-6679520,1,12p13,T,"171017,ENSG00000126746,Q8TF68,TNRC1,ZNF384"
ZNF521,zinc finger protein 521,25925,18:25062712-25350946,1,18q11.2,T,"25925,ENSG00000198795,Q96K83,ZNF521"
ZRSR2,"zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2",8233,X:15790496-15823242,1,Xp22.1,"F, S, Mis","8233,ENSG00000169249,Q15696,U2AF1L2,ZRSR2"
